81. List Of Company Managers rolf Hildner DZ Bank,. rolf Kunisch Beiersdorf,. rolf M zinkernagel NovartisAG,. rolf Schäuble Baloise Group,. rolf SchmidtHoltz BMG (Bertelsmann http://www.transnationale.org/manager/manager_R.htm

Home : Companies > List of managers: A B C D ... Q R S T U V ... Z R Arletti: Ricchetti Gruppo Ceramiche SpA R Bell: Tomkins PLC R Christopher Hoehn-Saric: Sylvan Learning Systems R David Alexander, Jr: Family Dollar Stores, Inc R David Schmaier: Siebel Systems, Inc R Donald Newman: Bowater Inc. R Edward Flood: Ivanhoe Mines Ltd. R Everaert: Telindus Group R Foster Duncan: Cinergy R Glenn Hilliard: Conseco Inc. R James Kelly: Family Dollar Stores, Inc R L Pennant-Rea: BAT (British American Tobacco plc) R L van Iperen: Oce NV. R Louis Schneeberger: OM Group, Inc R M Premkumar: Food Corporation of India R Maleve: Telindus Group R Michael Hembree: Printpack, Inc R Neal Black: Jos. A. Bank Clothiers, Inc R Patrick Simms: Diversa Corp R Pieterse: Wolters Kluwer NV. R S Braddock: Lincoln Center for Performing Arts, Eastman Kodak Co. Priceline.com R S Sharma: R Smith: Cytec Industries Inc. R Stephen Barrett: Whirlpool Corp. R Stephen Briggs: Protective Life Corp. R Steve Letbetter: CenterPoint Energy ex-Reliant Energy Inc. R ter Haar: Hagemeyer NV R. Brad Martin: Saks Inc R. Chad Dreier: Ryland Group, Inc.

82. Zürcher Universitätsverein Professor Dr. rolf M. zinkernagel is the head of the institute for experimentalimmunology of the University of Zurich. After his studies at the medical http://www.zhv.unizh.ch/level2/level3/zProminente.en.html

ZURICH UNIVERSITY ALUMNI ASSOCIATION About the Association People Former fellow-students Well-known members Executive Committee Contacts Membership Contributions ... Web site of the FAN Well-known members Many well-known personalities from the fields of research, economics and politics are amongst the approximately 4000 members of the ZUNIV. Some of these personalities we would like to briefly introduce. Prof. Dr. M. Zinkernagel Professor Dr. Rolf M. Zinkernagel is the head of the institute for experimental immunology of the University of Zurich. After his studies at the medical faculty of the University of Basel, Professor Rolf M. Zinkernagel continued his studies in the USA and in Australia, as well as at the University of Zurich. He has earned great honours and received many distinctions in science in the last twenty years; the 1996 Nobel-prize for medicine being perhaps the most prestigious. He is of great service to many important organisations as a scientific counsellor. To the Academic Trainee Fund, which was founded by the ZUNIV, Professor Dr. Rolf M. Zinkernagel is committed as a counsellor as well. Bruno Frick, Deputy of the canton of Schwyz

83. On Ontogeny Specificity And Memory Of Virus Specific Cytotoxic T Cells And B Cel rolf M. zinkernagel (Project Leader). rolf.zinkernagel@usz.ch. Prof.Hans Hengartner (Project Leader) rolf M. zinkernagel, Prof. Hans Hengartner http://www.research-projects.unizh.ch/med/unit43100/area435/p3170.htm

research project On ontogeny specificity and memory of virus specific cytotoxic T cells and B cells Studies on T cell specificity: Various parameters such as CD4, CD8, MHC I, MHC II, accessory molecules and adhesion molecules, peptide concentrations, membrane, lipid content and mobility will be studied and correlated with cytotoxic T cell effector function and induction requirements using various peptide densitiies and various infection routes. Response versus unresponsiveness by cytotoxic T cells: is there a therapeutic window where conditions of antigen encounter result in no induction of a T cell response, or in induction of an efficient protective T cell response or in complete deletion of T cells. What are the generalisable rules for immunological ignorance, protective induction versus overinduction/exhaustion. Various model situations including LCMV infections, LCMV-glycoprotein expressing transgenic mice and the HY male model will be used. T cell memory versus protective immunity: Under what conditions are memory T cells (quicker and higher) antigen independently versus antigen dependently maintained and how does this correlate with effective protection in model situations where the cytotoxic T cell response is limiting. IgE responses against skin and mucosal ectoparasites: Model infections with mites and two verm were infections (Nippostrongylus, H. polygrus) have been established to evaluate the basic rules of IgE induction under infection conditions. Local versus systemic repsonses will be compared and local versus systemic in parameters will be analysed.

84. Allegro-Chronik 25 Jahre (2005) zinkernagel, rolf M. 1997, Prusiner, StanleyB. Wiesel, Torsten Nils Schweden (1981) zinkernagel, rolf M. (1996) http://www.allegro-c.de/chronik/a28m.htm

25 Jahre allegro Nobelpreis Medizin Jahr Nobelpreis Medizin Bancerraf, Baruj; Snell, George D.; Dausset, Jean Hubel, David H.; Sperry, Roger W.; Wiesel, Torsten Nils [Schweden] Bergstr¶m, Sune K.; Samuelsson, Bengt I.; Vane, John R. McClintock, Barbara Jerne, Niels K; K¶hler, Georges J.S.; Milstein, C©sar Brown, Michael S.; Goldstein, Joseph L. Levi-Montalcini [Italien]; Cohen, Stanley Tonegawa, Susumu Elion, Gertrude B; Hitchings, George H.; Black, James [UK] Bishop, J. Michael; Varmus, Harold E. Murray, Joseph E.;Thomas, E. Donnall Neher, Erwin; Sakmann, Bert Fischer, Edmond H.; Krebs, Edwin G. Roberts, Richard J.; Sharp, Phillip A. Lewis, Edward B.; N¼sslein-Volhard, Christiane; Wieschaus, Eric F. Doherty, Peter C. [Australien]; Zinkernagel, Rolf M. Prusiner, Stanley B. Furchgott, Robert F.; Ignarro, Luis J.; Murad, Ferid Blobel, G¼nter [Deutschland] Carlsson, Arvid [Schweden] Hartwell, Leland H.; Hunt, R. Timothy [UK]; Nurse, Paul M. [UK] Brenner, Sydney [UK]; Horwitz, H. Robert; Sulston, John E. [UK] Lauterbur, Paul C.; Mansfield, Sir Peter Gilman, Alfred G.; Rodbell, Martin

85. University Of Zurich - About The University In 1996, Professor rolf M. zinkernagel, Director of the Institute for ExperimentalImmunology, was awarded the Nobel Prize for Medicine together with the http://www.unizh.ch/info/universitaet/nobel.en.html

ABOUT THE UNIVERSITY History in brief The University in Figures Nobel Prize Winners Faculties Nobel Prize Winners Rolf M. Zinkernagel 1996 Nobel Prize for Medicine together with Peter Doherty "For research on the biochemical mechanism with which the immune system recognizes and destroys virus-infected cells." Born 6.1.1944 in Basel In 1996, Professor Rolf M. Zinkernagel, Director of the Institute for Experimental Immunology, was awarded the Nobel Prize for Medicine together with the Australian researcher Peter C. Doherty. They were both honoured for discovering how the human immune system can distinguish between infected and non-infected cells. Today Zinkernagel works, together with Professor Hans Hengartner and 30 colleagues, on so-called autoimmune diseases such as juvenile diabetes and multiple sclerosis. At the University of Zurich: since 1979 Professor of Experimental Immunology 1987 Nobel Prize for Physics together with George Bednorz "For their important breakthrough in the field of superconductivity." Born 20.4.1927 in Basel

86. WDR - Rundum Gesund - Argumente Der Impfkritiker Translate this page Der Schweizer Professor rolf M. zinkernagel erhielt im Jahr 1996 wegen seiner rolf M. zinkernagel On Natural and Artificial Vaccinations (Review) http://www.wdr.de/tv/rundumgesund/sendungen_2005/20050418/impfkritik.jhtml

Donnerstag, 15.09.2005 Aktuelle Sendung Nächste Sendung Fitness Ernährung ... Rezepte Archiv nach Sendedatum nach Stichworten Download Newsletter ... wdr.de-Gesundheit SENDUNG VOM 18.4.2005 Argumente der Impfkritiker von Michael Houben Warum können die Impfstoffe ernste Schäden anrichten? Warum kann es - wenn auch in sehr seltenen Fällen - unmittelbar nach einer Impfung zur Epilepsie und anderen ernsten Krankheiten kommen, warum schlagen einige Erreger scheinbar doch etwas häufiger nach einer Impfung zu? Warum können Impfungen niemals so wirkungsvoll und lebenslang gegen den erneuten Ausbruch einer Krankheit schützen wie eine Immunisierung durch Krankheit? Impfkritiker sehen dafür mehrere Ursachen und durchaus auch schulmedizinisch nachvollziehbare Mechanismen. Die Theorie der aktiven Impfung ist eigentlich einfach: Man spritzt den abgeschwächten Erreger, in neuerer Zeit sogar nur Oberflächenbestandteile des Erregers einer Krankheit in den Körper. Das Immunsystem des Impflings lernt den Erreger kennen, bildet Antikörper gegen den Erreger bzw. speichert deren Bauplan. Wenn der unabgeschwächte Verwandte des Impfstoffes dann den Körper angreift, kann das Immunsystem sehr viel schneller aktiv werden und die Krankheit rechtzeitig eindämmen bzw. gar nicht erst zum Ausbruch kommen lassen. Bei der passiven Impfung werden direkt Antikörper verabreicht, z.B. nach einem Biss eines tollwütigen Hundes oder bei einer Schwangeren ungeimpften Frau nach Kontakt mit Röteln. Die Historie der Impfung ist in den Annalen der Schulmedizin als Erfolgsgeschichte eingegangen. Doch manche der dem Impfen eher skeptisch gegenüberstehen entdecken in dieser Erfolgsgeschichte auch einige Irrtümer und Wirrungen, bis hin zu Hinweisen, dass die größten Erfolge vielleicht doch nicht auf die Impfungen zurückzuführen sind.

87. WDR - Rundum Gesund - Argumente Der Impfkritiker - Druckversion Translate this page Der Schweizer Professor rolf M. zinkernagel erhielt im Jahr 1996 wegen seinerArbeiten zur Immunologie den Nobelpreis für Medizin. http://www.wdr.de/tv/rundumgesund/sendungen_2005/20050418/ZZ_DRUCKVERSION/impfkr

Stand vom 18.04.2005 Argumente der Impfkritiker von Michael Houben Warum können die Impfstoffe ernste Schäden anrichten? Warum kann es - wenn auch in sehr seltenen Fällen - unmittelbar nach einer Impfung zur Epilepsie und anderen ernsten Krankheiten kommen, warum schlagen einige Erreger scheinbar doch etwas häufiger nach einer Impfung zu? Warum können Impfungen niemals so wirkungsvoll und lebenslang gegen den erneuten Ausbruch einer Krankheit schützen wie eine Immunisierung durch Krankheit? Impfkritiker sehen dafür mehrere Ursachen und durchaus auch schulmedizinisch nachvollziehbare Mechanismen. Die Theorie der aktiven Impfung ist eigentlich einfach: Man spritzt den abgeschwächten Erreger, in neuerer Zeit sogar nur Oberflächenbestandteile des Erregers einer Krankheit in den Körper. Das Immunsystem des Impflings lernt den Erreger kennen, bildet Antikörper gegen den Erreger bzw. speichert deren Bauplan. Wenn der unabgeschwächte Verwandte des Impfstoffes dann den Körper angreift, kann das Immunsystem sehr viel schneller aktiv werden und die Krankheit rechtzeitig eindämmen bzw. gar nicht erst zum Ausbruch kommen lassen. Bei der passiven Impfung werden direkt Antikörper verabreicht, z.B. nach einem Biss eines tollwütigen Hundes oder bei einer Schwangeren ungeimpften Frau nach Kontakt mit Röteln. Die Historie der Impfung ist in den Annalen der Schulmedizin als Erfolgsgeschichte eingegangen. Doch manche der dem Impfen eher skeptisch gegenüberstehen entdecken in dieser Erfolgsgeschichte auch einige Irrtümer und Wirrungen, bis hin zu Hinweisen, dass die größten Erfolge vielleicht doch nicht auf die Impfungen zurückzuführen sind.

88. NobelpreistrŠger Rolf M. Zinkernagel Translate this page rolf M. zinkernagel und Peter C. Doherty erhalten den diesjährigen, rolf M.zinkernagel ist der 24. Schweizer Nobelpreisträger und der zwölfte, http://www.unicom.unizh.ch/journal/archiv/6-96/nobelpreis.html

[Rolf M. Zinkernagel: Zur Person] [Die Entdeckung] zink@pathol.unizh.ch Rolf M. Zinkernagel: Land, in dem viele der Wissenschaft skeptisch (Bild: Lucia Degonda) Wie sieht denn Ihr Alltag aus, wenn Sie keine Interviewtermine haben? Zum Beispiel? (Bild: Lucia Degonda) Wie stellen Sie sich das vor? Paul Schneeberger Zur Person Professor Rolf M (ps) Die Entdeckung Chemie: Physik: Medizin: Literatur: (ps) uni Nicolas Jene ( upd@zuv.unizh.ch http://www.unizh.ch/upd/journal/ Last update: 11.12.1996

89. HistoryForSale - Exploration & Science Autographs Autographs rolf M. zinkernagel FIRST DAY COVER SIGNED CIRCA 1952 rolf M.zinkernagel - FIRST DAY COVER SIGNED CIRCA 1952 - DOCUMENT 267582, $149.00 http://www.historyforsale.com/html/display.aspx?page=153&sort=0&signer=Z&dpp=25

90. HistoryForSale - Nobel Prize Autographs Autographs rolf M. zinkernagel FIRST DAY COVER SIGNED CIRCA 1962 rolf M.zinkernagel - FIRST DAY COVER SIGNED CIRCA 1962 - DOCUMENT 267580, $149.00 http://www.historyforsale.com/html/display.aspx?page=62&sort=0&signer=Z&dpp=25

91. Viral Persistence In Vivo Through Selection Of Neutralizing Antibody-escape Vari Contributed by rolf M. zinkernagel, December 20, 1999. Despite initial viruscontrol by CD8+ cytotoxic T lymphocytes (CTLs), noncytopathic or variably http://www.pnas.org/cgi/content/abstract/97/6/2749

Published online before print February 25, 2000, 10.1073/pnas.040558797 March 14, 2000 This Article Full Text Full Text (PDF) Alert me when this article is cited ... Citation Map Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal ... Cited by other online articles Search for citing articles in: ISI Web of Science (53) PubMed PubMed Citation Articles by Ciurea, A. Articles by Zinkernagel, R. M. Vol. 97, Issue 6, 2749-2754, March 14, 2000 Immunology Viral persistence in vivo through selection of neutralizing antibody-escape variants Adrian Ciurea Paul Klenerman, Lukas Hunziker, Edit Horvath, Beatrice M. Senn, Adrian F. Ochsenbein, Hans Hengartner, and Rolf M. Zinkernagel Institute for Experimental Immunology, University Hospital, CH-8091 Zurich, Switzerland Contributed by Rolf M. Zinkernagel, December 20, 1999 Despite initial virus control by CD8 cytotoxic T lymphocytes (CTLs), noncytopathic or variably cytopathic viruses (e.g., hepatitis B and C viruses, HIV) are able to establish persistent infections.

92. Persistence Of Lymphocytic Choriomeningitis Virus At Very Low Levels In Immune M Contributed by rolf M. zinkernagel, August 13, 1999. Lymphocytic choriomeningitisvirus (LCMV), strain WE, is a noncytopathic RNA virus that is highly http://www.pnas.org/cgi/content/abstract/96/21/11964

This Article Full Text Full Text (PDF) Alert me when this article is cited ... Citation Map Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal ... Cited by other online articles Search for citing articles in: ISI Web of Science (54) PubMed PubMed Citation Articles by Ciurea, A. Articles by Zinkernagel, R. M. Vol. 96, Issue 21, 11964-11969, October 12, 1999 Immunology Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice Adrian Ciurea Paul Klenerman Lukas Hunziker, Edit Horvath, Bernhard Odermatt, Adrian F. Ochsenbein, Hans Hengartner, and Rolf M. Zinkernagel Institute for Experimental Immunology, Department of Pathology, University Hospital, CH-8091 Zurich, Switzerland Contributed by Rolf M. Zinkernagel, August 13, 1999 Lymphocytic choriomeningitis virus (LCMV), strain WE, is a non-cytopathic RNA virus that is highly adapted to its natural host, the mouse. Acute infection of adult mice leads to generalized

93. Induction Of Protective Cytotoxic T Cell Responses In The Presence Of High Titer Dagger Hans Hengartner,* and rolf M. zinkernagel* P. Seiler, BM Senn, M.A.Brundler, RM zinkernagel, H. Hengartner, and U. Kalinke http://www.jem.org/cgi/content/abstract/187/4/649

Home Help Feedback Subscriptions ... Table of Contents This Article Full Text PDF (Full Text) Alert me when this article is cited ... Citation Map Services Alert me to new content in the JEM Download to citation manager Cited by other online articles PubMed PubMed Citation Articles by Seiler, P. Articles by Zinkernagel, R. M. J. Exp. Med., Volume 187, Number 4, February 16, 1998 649-654 BRIEF DEFINITIVE REPORT: Induction of Protective Cytotoxic T Cell Responses in the Presence of High Titers of Virus-neutralizing Antibodies: Implications for Passive and Active Immunization By Peter Seiler, Christine Zimmermann, Doris Weibel, Michael Bruns, Hans Hengartner, and Rolf M. Zinkernagel From the The effect of preexistent virus-neutralizing antibodies on the active induction of antiviral T cell responses was studied in two model infections in mice. Against the noncytopathic lymphocytic choriomeningitis virus (LCMV), pretreatment with neutralizing antibodies conferred immediate protection against systemic virus spread and controlled the virus below detectable levels. However

94. JEM -- Index By Author: Mar 6 2000; 191 (5) A B C D E F G H I J K L M N O P Q R S T Zaghouani, Habib Abstract Full Text zinkernagel, rolf M. Abstract http://www.jem.org/content/vol191/issue5/aindex.shtml

HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS Index by Author: Mar 6 2000; 191 (5) [Table of Contents] A B C ... E F G H I J K L M ... P Q R S T U ... W X Y Z A Allen, Melanie [Abstract] [Full Text] Andersen, Peter S. [Abstract] [Full Text] Anderson, Ana C. [Abstract] [Full Text] Arstila, T. Petteri [Abstract] [Full Text] Arstila, Tuula [Abstract] [Full Text] B Behrens, Timothy W. [Abstract] [Full Text] Boone, David L. [Full Text] Brasel, Kenneth [Abstract] [Full Text] Brown, Sandra N. [Abstract] [Full Text] Brown, Melissa A. [Abstract] [Full Text] Butz, Eric A. [Abstract] [Full Text] C [Abstract] [Full Text] Chang, Y.C. [Abstract] [Full Text] Chappel, Suzanne M. [Abstract] [Full Text] Charrier, Keith [Abstract] [Full Text] Churchill, Hywyn R.O. [Abstract] [Full Text] D Damen, Jacqueline E. [Abstract] [Full Text] E Ehrhardt, Rolf O. [Abstract] [Full Text] Embers, Monica [Abstract] [Full Text] G Gabel, Christopher A. [Abstract] [Full Text] Glaccum, Moira [Abstract] [Full Text] Goverman, Joan [Full Text] Gutekunst, Claire-Anne [Abstract] [Full Text] Guy-Grand, Delphine [Abstract] [Full Text] H Hambor, John [Abstract] [Full Text] Helgason, Cheryl D.

95. Doherty, Zinkernagel Win Nobel Prize, NIAID News Release Peter C. Doherty, Ph.D., an NIAID grantee since 1977, and rolf M. zinkernagel,Ph.D., an NIAID grantee in the late 1970s and mid1980s, received the award http://www2.niaid.nih.gov/Newsroom/Releases/nobel.htm

Search Help Site Index Contact Us NIAID ... Resources National Institute of Allergy and Infectious Diseases (NIAID) http://www.niaid.nih.gov FOR IMMEDIATE RELEASE Tuesday, Oct. 8, 1996 Media Contact: Greg Folkers niaidnews@niaid.nih.gov Doherty, Zinkernagel Win Nobel Prize "The National Institute of Allergy and Infectious Diseases (NIAID) is very pleased that two of our colleagues in immunology research, one of whom is a long-term grantee, have been awarded the 1996 Nobel Prize in Physiology or Medicine," says Anthony S. Fauci, M.D., NIAID director. Peter C. Doherty, Ph.D., an NIAID grantee since 1977, and Rolf M. Zinkernagel, Ph.D., an NIAID grantee in the late 1970s and mid-1980s, received the award today for their discovery of how the immune system recognizes virus-infected cells. "Their observations paved the way for the current understanding of how the immune system recognizes both microbial invaders and the body's own cells," says Dr. Fauci. The two scientists collaborated on their prize-winning research between 1973 and 1975 at the John Curtin School of Medical Research in Canberra, Australia. Dr. Doherty is currently chairman of the immunology department at St. Jude Children's Research Hospital in Memphis, Tenn., and holds the hospital's Michael F. Tamer Endowed Chair for Immunology Biomedical Research. Dr. Zinkernagel is professor and director of the Institute of Experimental Immunology at the University of Zurich in Switzerland. "Dr. Doherty and Dr. Zinkernagel established that the immune system recognizes microbial antigens in association with self molecules known as major histocompatibility antigens on a cell's surface," says Dr. Fauci. "Not only did their observations reveal how the immune system recognizes microbial invaders, but they also helped us understand, more broadly, how the immune system recognizes a molecule as self or non-self."

96. International: Italiano: Salute: Medicina: Medici E Ricercatori: Zinkernagel, Ro Translate this page Salute Medicina Medici e Ricercatori zinkernagel, rolf - Open Site. In tutta la Directory, Solo in Medici_e_Ricercatori/zinkernagel,_rolf http://open-site.org/International/Italiano/Salute/Medicina/Medici_e_Ricercatori

Open Site The Open Encyclopedia Project Pagina principale Aggiungi Contenuti Diventa Editore In tutta la Directory Solo in Medici_e_Ricercatori/Zinkernagel,_Rolf Top International Italiano Salute ... Medici e Ricercatori : Zinkernagel, Rolf Vedi anche: International: Italiano: Societ : Strutture Sociali: Persone: Biografie: Premio Nobel Questa Categoria ha bisogno di un Editore - Richiedila Open Site Code 0.5.3 robot company. Visit our sister sites dmoz.org mozilla.org chefmoz.org musicmoz.org ... modifica

97. Enhanced Virus Clearance By Early Inducible Lymphocytic Choriomeningitis Virus-N Peter Seiler,1,* Ulrich Kalinke,1 Thomas Rülicke,2 Etienne M. Bucher,1 ChristianBöse,1, dagger rolf M. zinkernagel,1 and Hans Hengartner1 http://jvi.asm.org/cgi/content/abstract/72/3/2253

This Article Full Text Full Text (PDF) Alert me when this article is cited ... Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager ... Books from ASM Press PubMed PubMed Citation Articles by Seiler, P. Articles by Hengartner, H. J Virol, March 1998, p. 2253-2258, Vol. 72, No. 3 American Society for Microbiology Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice Peter Seiler, Ulrich Kalinke, Etienne M. Bucher, Rolf M. Zinkernagel, and Hans Hengartner Department of Pathology, Institute of Experimental Immunology, University of Zurich, and Biologisches Zentrallabor, University Hospital Zurich, CH 8091 Zurich, Switzerland Received 1 October 1997/Accepted 24 November 1997 Following infection of mice with lymphocytic choriomeningitis virus (LCMV), virus-neutralizing antibodies appear late, after 30 to 60 days. Such neutralizing antibodies play an important

98. Entrez PubMed rolf M. ZinkernagelFelix HoppeSeyler Lecturer 1997. Hagmann M, Schaffner.Publication Types Biography Editorial Historical Article Lectures MeSH Terms http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9

99. Université De Lausanne - Zinkernagel http://www.unil.ch/central/page4913_fr.html

Site map Annuaires Recherche Langues: fr L'UNIL en bref L'enseignement La recherche L'organisation ... Prix Nobel Rolf M. Zinkernagel Prix et distinctions scientifiques 1981 Cloetta Stiftung, Zurich. 1982 Jung Stiftung, Hamburg. 1983 Prix Paul Ehrlich, Frankfurt. 1985 Prix Mack-Forster, Europ Ass Clin Inv. 1986 Gairdner Foundation International Award, Toronto. 1987 Institut pour la recherche sur le cancer, New York. 1988 Naegeli Stiftung, Zurich. 1995 The Albert Lasker Medical Research Award. Version imprimable MyUNIL > Droit > Lettres > SSP - Sciences Sociales et Politiques > HEC - Ecole des Hautes Etudes Commerciales Environnement Contact Impressum Login

100. Zinkernagel Maternal Antibodies Childhood Infection Impfo.ch http://www.impfo.ch/htm-dokumente/RZinkernagel.htm

www.impf o .ch/PROBLEMASPEKT.htm Rolf M. Zinkernagel: Maternal Antibodies, Childhood Infections, and Autoimmune Disease (Review) N Engl J Med 2001; 345: 1331-35 vergleiche auch vom gleichen Autor: On Natural and Artificial Vaccinations (Annu. Rev. Immunol. 2003) Zusammenfassung: Anmerkung: 30.10.2002, Peter Klein

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-100 of 103    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20